Nicotine users received a one-two punch late last month, when the Biden administration simultaneously announced its intention to slash the allowable level of nicotine in cigarettes and to push the popular e-cigarette brand Juul off the market.
The apparent contradiction of targeting both cigarettes and vaping, when the latter reduces the harm of the former, sent many reeling. But it's characteristic of the administration's often incoherent moves in this area.
The administration, and the FDA specifically, needs to articulate a sensible strategy for reducing harm from addictive nicotine products. If laws like the 2009 Tobacco Control Act are forcing FDA to take actions contrary to public health, the administration should say so.
Continue reading the entire piece here at Newsweek
______________________
Charles Fain Lehman is a fellow at the Manhattan Institute and a contributing editor of City Journal. Follow him on Twitter here.
Randall Lutter is a senior fellow at the Manhattan Institute.
This piece originally appeared in Newsweek